Lucira Health Announces U.S. Launch of First & Only At-Home Combination COVID-19 & Flu Test Amidst Sale Process
28 mars 2023 08h05 HE
|
Lucira Health Inc.
Lab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but different treatments, requiring a fast, differential test to access...
Lucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy Filing
27 févr. 2023 08h00 HE
|
Lucira Health Inc.
Lab-quality results for both COVID-19 and Flu now available at home from one single testCOVID-19 and Flu have similar symptoms but different treatments, requiring a fast, differential test to access...
Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
22 févr. 2023 17h15 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company, announced today that it has filed...
Lucira Health Launches Lucira Connect, a Free Test-to-Treat Telehealth Service for Covid-19 or Flu in Canada
04 janv. 2023 07h00 HE
|
Lucira Health Inc.
For $98 CAD Canadians will receive a free telehealth appointment included with purchase of a testLucira Connect provides lab-quality at-home test-users a telehealth visit at no additional cost,...
Lucira Health Submits EUA for Over-The-Counter (OTC) Use of its COVID-19 & Flu Test
03 janv. 2023 07h00 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health" or "Lucira"), a medical technology company, announced that it submitted an Emergency Use...
Lucira and Loch Lomond Villa Announce Clinical Study to Tackle Tripledemic With First and Only Combination COVID-19 and Flu OTC Molecular Self-Test
06 déc. 2022 07h03 HE
|
Lucira Health Inc.
Lucira COVID-19 & Flu Test is the first and only combination over-the-counter (OTC) self-test with fast, molecular lab-quality results enabling mass testing of symptomatic residents, staff and...
Lucira Health Announces FDA Authorization of Combination COVID-19 & Flu Test at Point-of-Care
22 nov. 2022 16h02 HE
|
Lucira Health Inc.
PCR Lab-quality NAAT/molecular test for both COVID-19 and flu from 1 shallow nasal swabPositive result as quickly as 11 minutes, negative result in 30 minutes, allowing diagnosis during patient...
Lucira Health Announces National Launch of Lucira Connect Test-to-Treat Service
17 nov. 2022 07h03 HE
|
Lucira Health Inc.
Digital health service offers Lucira lab-quality at-home test users a telehealth visit at no additional cost, enabling Test-to-Treatment within hours for only $29, excluding prescription costsLucira...
Lucira Health Announces Third Quarter 2022 Results and Provides Business Updates
14 nov. 2022 16h02 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and...
Lucira Health to Announce Third Quarter 2022 Financial Results
01 nov. 2022 07h00 HE
|
Lucira Health Inc.
EMERYVILLE, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of...